Shapiro Quoted on CBD Warning Letters in Vitamin Retailer

March 29, 2021 | Compliance Investigations & White Collar | Cannabis

Steven Shapiro was quoted in the Vitamin Retailer article, “FDA Warns Selling of Topical CBD Products Violates FD&C Act.

The FDA has issued warning letters to two companies addressing the illegal marketing of unapproved drugs labeled as containing CBD.

Shapiro questions the letters as neither discussed the potential to use CBD as an inactive ingredient intended for cosmetic benefit.

Read the full article.


Share this article:
  • Steven Shapiro

Related News

Get legal updates and news delivered to your inbox